Cite

HARVARD Citation

    Clarke, J. et al. (n.d.). A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma. Neuro-oncology. 16 (7), pp. 984-990. [Online]. 
  
Back to record